In this third in a series of podcasts focused on rare disease patient advocates jointly produced by The Burrill Report, the California Healthcare Institute, and the Children’s Rare Disease Network, we speak to Susan Cornelius, business advisor to The Nicholas Conor Institute for Pediatric Cancer Research. When her granddaughter struggled against cancer, she was frustrated that new technology was unavailable to her and that all doctors could offer were surgery, radiation or chemotherapy – what she characterized as cut, burn, or poison the child for a disease, in her granddaughter’s case, that was genetically-based. Cornelius lost her granddaughter to cancer in 2008, but now works to bring about changes to the way cancer research is conducted.
Subscribe to RARE Blog
Subscribe to this blog and receive notifications of new posts by email.
Tags
blue denim ribbon Charity Children children's rare diseases children rare disease childrens rare disease network Children with Rare Disease Collaboration communication CONGRESS disease Emil Kakkis FDA Francis Collins genetic conditions Genetics Genzyme global genes Global Genes Project health howard liebers joubert syndrome Kakkis EveryLife Foundation kids marbleroad National Institutes of Health nicole boice NIH NORD orphan disease Orphan Drug Act orphan drugs pediatric rare disease public awareness RARE Blog Rare Disease rare disease and children Rare Disease Day Rare Disease Registry Rare Disease Research rare disorder rare disorders rare project Undiagnosed World Rare Disease Day



